Trial intelligence / Profile preview

EVICEL Fibrin Sealant for Hemostasis in Pediatric Abdominal, Pelvic, Retroperitoneal or Thoracic Surgery

2013-003401-26Phase 4Completed

Sponsor
Ethicon
Start
Dec 2013
Modality
Recombinant Proteins and Enzymes, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems, Implantable Hydrogels → Hydrogel Systems → Drug Delivery Systems
Countries
1
01

Overview

Phase 4, randomised trial of porcine fibrin sealant in Not applicable (2 arms), sponsored by Ethicon. Primary endpoint: Absolute time to haemostasis. Started Dec 2013; status: completed.

02

Drugs

porcine fibrin sealant
03

Conditions

Not applicable

Beyond the preview

Go deeper on 2013-003401-26.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2013-003401-26.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call